Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Oral Propranolol on mRNA Expression in Symptomatice Caavernous Malformation

NCT03474614 is registered in ClinicalTrials.gov with St. Joseph's Hospital and Medical Center, Phoenix as lead sponsor.

NCT NCT03474614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03474614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Oral Propranolol on mRNA Expression in Symptomatice Caavernous Malformation
Lead sponsor
St. Joseph's Hospital and Medical Center, Phoenix
Phase
Phase 2
Overall status
Terminated
Start date
January 24, 2018
Completion date
February 11, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral cavernous malformations